XML 43 R37.htm IDEA: XBRL DOCUMENT v3.24.3
Common Share - Additional Information (Details)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
May 31, 2024
USD ($)
May 29, 2024
€ / shares
shares
Mar. 05, 2024
USD ($)
$ / shares
shares
Aug. 14, 2023
USD ($)
Aug. 09, 2023
€ / shares
shares
May 22, 2023
USD ($)
May 31, 2021
USD ($)
Jun. 30, 2023
USD ($)
shares
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
shares
Sep. 30, 2024
€ / shares
Sep. 30, 2024
USD ($)
shares
May 29, 2024
$ / shares
Feb. 29, 2024
USD ($)
Dec. 31, 2023
€ / shares
Dec. 31, 2023
USD ($)
shares
Aug. 09, 2023
$ / shares
Class of Stock [Line Items]                                    
Common shares, value, issued                         $ 6,919,000       $ 5,883,000  
Common shares, issued | shares                         68,426,779       57,825,879  
Gross proceeds, before deducting sales agent commissions                 $ 434,863,000 $ 225,945,000                
Common shares, par value | € / shares                       € 0.09       € 0.09    
Sales Agreement                                    
Class of Stock [Line Items]                                    
Common shares, issued | shares                     2,720,846              
Common shares, sold | shares               3,272,280                    
Gross proceeds, before deducting sales agent commissions               $ 65,500,000     $ 59,500,000              
Sales agent commissions                     $ 1,700,000              
Net proceeds, after deducting sales agent fees, underwriting discounts and commissions           $ 124,900,000   $ 63,800,000                    
Sales Agreement | Maximum                                    
Class of Stock [Line Items]                                    
Shares sale agreement authorized amount           $ 125,000,000 $ 125,000,000                      
Underwriting commissions rate of gross proceeds of shares sold             3.00%                      
Underwriting Agreement                                    
Class of Stock [Line Items]                                    
Common shares, sold | shares         6,818,182                          
Net proceeds, after deducting sales agent fees, underwriting discounts and commissions       $ 162,200,000                            
Sale of shares, price per share | $ / shares                                   $ 22
Common shares, par value | € / shares         € 0.09                          
Additional common shares at public offering price | shares         1,022,727                          
Gilead Collaboration Agreement                                    
Class of Stock [Line Items]                                    
Common shares, sold | shares     452,527                              
Common shares stated purchase price per share | $ / shares     $ 55.2454                              
Gross proceeds, before deducting sales agent commissions     $ 25,000,000                              
2024 Sales Agreement                                    
Class of Stock [Line Items]                                    
Common shares, issued | shares                         0          
2024 Sales Agreement | Maximum                                    
Class of Stock [Line Items]                                    
Shares sale agreement authorized amount                             $ 300,000,000      
Underwriting commissions rate of gross proceeds of shares sold                 3.00%                  
2024 Underwriting Agreement                                    
Class of Stock [Line Items]                                    
Common shares, sold | shares   7,550,000                                
Net proceeds, after deducting sales agent fees, underwriting discounts and commissions $ 434,900,000                                  
Sale of shares, price per share | $ / shares                           $ 53        
Common shares, par value | € / shares   € 0.09                                
Additional common shares at public offering price | shares   1,132,500